Beijing SL Pharmaceutical Co., Ltd.

SZSE:002038.SZ

11.69 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001
Omzet 652.6341,018.3591,050.1651,214.8111,112.7342,029.7042,167.4721,242.0761,009.8471,156.5481,242.9521,161.7791,007.018622.772457.842390.025358.003237.531143.936118.55893.05171.05149.90532.183
Kosten van de omzet 211.533187.787156.956183.574163.422417.379448.275364.31351.265393.589372.427378.621330.306153.115106.74266.98449.03681.62653.12845.90732.45820.64711.5114.773
Brutowinst 441.101830.572893.211,031.236949.3121,612.3251,719.197877.766658.583762.96870.525783.158676.711469.658351.1323.041308.967155.90590.80972.65160.59350.40438.39427.41
Brutowinstmarge 0.6760.8160.8510.8490.8530.7940.7930.7070.6520.660.70.6740.6720.7540.7670.8280.8630.6560.6310.6130.6510.7090.7690.852
Onderzoek- en ontwikkelingskosten 149.623177.107161.649196.147188.641128.35372.89473.68255.0292.30158.78788.38973.97259.88258.1810040.805000000
Algemene en administratieve kosten 11.29312.73123.49915.54619.39823.56411.10811.2614.26412.76114.51118.28912.2395.2562.80763.87159.9178.21931.16329.18317.02511.58610.9354.914
Verkoop- en marketingkosten 109.423263.871426.799481.668496.3890.227911.164369.41783.84333.66530.38931.13134.76718.02918.9814.39811.25510.7539.50210.0349.6716.2445.2941.622
Verkoop-, algemene en administratieve kosten 120.715276.603450.299497.215515.698913.79922.272380.67798.10746.42644.949.4247.00623.28521.78778.26971.17318.97240.66539.21626.69717.8316.236.535
Overige kosten 298.151-102.02899.24782.72975.5766.4-9.9910.99720.18111.93332.44419.2725.24911.40937.97710.1846.9869.6332.3440.9610.5430.693-0.0380.062
Bedrijfskosten 568.49352.702711.195776.091779.9091,108.5441,050.135490.857196.177186.169147.12175.354158.824103.66793.38983.00875.67162.01841.93640.11527.41418.29316.5846.725
Bedrijfsresultaat -119.603477.87263.317457.545412.881560.901681.637621.623507.181656.816780.477654.627555.09593.043281.576262.859228.997139.4557.43338.41435.31233.2121.84720.623
Bedrijfsresultaat ratio -0.1830.4690.2510.3770.3710.2760.3140.50.5020.5680.6280.5630.5510.9520.6150.6740.640.5870.3990.3240.3790.4670.4380.641
Totaal overige inkomsten en kosten netto -14.146-12.976-3.9650.292-0.101-0.013-9.9910.99720.18111.92931.93819.04643.236240.47761.96334.2876.9869.6333.5914.9171.529-0.18600
Inkomen voor belasting -133.75464.894259.352457.837412.779560.888671.646622.62527.363668.745812.415673.674560.339604.452319.553273.043235.983149.08458.18838.41435.28233.02421.84720.623
Inkomen voor belasting ratio -0.2050.4570.2470.3770.3710.2760.310.5010.5220.5780.6540.580.5560.9710.6980.70.6590.6280.4040.3240.3790.4650.4380.641
Belastingkosten -58.46349.93731.0136.5151.32681.39108.25293.86279.97791.528111.368101.66180.36180.06143.16829.29517.55614.2597.8474.5713.2891.8262.5531.719
Nettowinst -74.066416.692234.404425.94364.709486.784571.45533.575452.108575.049695.083577.397481.011523.345272.714244.105217.859134.80150.32133.82132.00231.219.29418.904
Nettowinstmarge -0.1130.4090.2230.3510.3280.240.2640.430.4480.4970.5590.4970.4780.840.5960.6260.6090.5680.350.2850.3440.4390.3870.587
WPA (Winst Per Aandeel) -0.070.410.230.410.360.470.830.520.440.560.680.560.470.510.270.240.220.130.0480.0340.0320.0430.0330.032
Verwaterde WPA -0.070.410.230.410.360.470.830.520.440.560.680.560.470.510.270.240.210.130.0470.0340.0320.0430.0330.032
EBITDA 196.726598.37363.784539.847492.843644.613735.52424.398487.759609.535863.736685.735538.218383.593271.39252.383247.835159.01262.79148.38344.45741.009-16.58420.709
EBITDA ratio 0.3010.5880.3460.4440.4430.3180.3390.3420.4830.5270.6950.590.5340.6160.5930.6470.6920.6690.4360.4080.4780.577-0.3320.643